Victory Capital Management’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $80.5K | Sell |
11,212
-289
| -3% | -$2.08K | ﹤0.01% | 2348 |
|
2025
Q1 | $68.9K | Buy |
11,501
+501
| +5% | +$3K | ﹤0.01% | 2343 |
|
2024
Q4 | $85.8K | Buy |
11,000
+508
| +5% | +$3.96K | ﹤0.01% | 2349 |
|
2024
Q3 | $113K | Buy |
+10,492
| New | +$113K | ﹤0.01% | 2312 |
|
2024
Q2 | – | Sell |
-11,470
| Closed | -$77.1K | – | 2491 |
|
2024
Q1 | $77.1K | Buy |
+11,470
| New | +$77.1K | ﹤0.01% | 2331 |
|
2020
Q2 | – | Sell |
-1,266
| Closed | -$2K | – | 2675 |
|
2020
Q1 | $2K | Buy |
+1,266
| New | +$2K | ﹤0.01% | 3630 |
|
2019
Q4 | – | Sell |
-583
| Closed | -$3K | – | 2773 |
|
2019
Q3 | $3K | Buy |
+583
| New | +$3K | ﹤0.01% | 3550 |
|
2018
Q2 | – | Sell |
-62,500
| Closed | -$2.78M | – | 1832 |
|
2018
Q1 | $2.78M | Buy |
+62,500
| New | +$2.78M | 0.01% | 976 |
|